Literature DB >> 19155496

T cell leukemia/lymphoma 1 and galectin-1 regulate survival/cell death pathways in human naive and IgM+ memory B cells through altering balances in Bcl-2 family proteins.

Siamak Jabbarzadeh Tabrizi1, Hiroaki Niiro, Mariko Masui, Goichi Yoshimoto, Tadafumi Iino, Yoshikane Kikushige, Takahiro Wakasaki, Eishi Baba, Shinji Shimoda, Toshihiro Miyamoto, Toshiro Hara, Koichi Akashi.   

Abstract

BCR signaling plays a critical role in purging the self-reactive repertoire, or in rendering it anergic to establish self-tolerance in the periphery. Differences in self-reactivity between human naive and IgM(+) memory B cells may reflect distinct mechanisms by which BCR signaling dictates their survival and death. Here we demonstrate that BCR stimulation protected naive B cells from apoptosis with induction of prosurvival Bcl-2 family proteins, Bcl-x(L) and Mcl-1, whereas it rather accelerated apoptosis of IgM(+) memory B cells by inducing proapoptotic BH3-only protein Bim. We found that BCR-mediated PI3K activation induced the expression of Mcl-1, whereas it inhibited Bim expression in B cells. Phosphorylation of Akt, a downstream molecule of PI3K, was more sustained in naive than IgM(+) memory B cells. Abundant expression of T cell leukemia/lymphoma 1 (Tcl1), an Akt coactivator, was found in naive B cells, and enforced expression of Tcl1 induced a high level of Mcl-1 expression, resulting in prolonged B cell survival. In contrast, Galectin-1 (Gal-1) was abundantly expressed in IgM(+) memory B cells, and inhibited Akt phosphorylation, leading to Bim up-regulation. Enforced expression of Gal-1 induced accelerated apoptosis in B cells. These results suggest that a unique set of molecules, Tcl1 and Gal-1, defines distinct BCR signaling cascades, dictating survival and death of human naive and IgM(+) memory B cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19155496     DOI: 10.4049/jimmunol.182.3.1490

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  A critical role of c-Cbl-interacting protein of 85 kDa in the development and progression of head and neck squamous cell carcinomas through the ras-ERK pathway.

Authors:  Takahiro Wakasaki; Muneyuki Masuda; Hiroaki Niiro; Siamak Jabbarzadeh-Tabrizi; Kumiko Noda; Tadayoshi Taniyama; Shizuo Komune; Koichi Akashi
Journal:  Neoplasia       Date:  2010-10       Impact factor: 5.715

2.  Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset.

Authors:  Edgar D Charles; Claudia Brunetti; Svetlana Marukian; Kimberly D Ritola; Andrew H Talal; Kristen Marks; Ira M Jacobson; Charles M Rice; Lynn B Dustin
Journal:  Blood       Date:  2011-03-18       Impact factor: 22.113

3.  Lack of galectin-1 or galectin-3 alters B cell deletion and anergy in an autoantibody transgene model.

Authors:  Amy G Clark; Melissa L Weston; Mary H Foster
Journal:  Glycobiology       Date:  2013-04-01       Impact factor: 4.313

4.  Galectins in hematological malignancies.

Authors:  Yves St-Pierre
Journal:  Am J Blood Res       Date:  2011-09-07

5.  Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response.

Authors:  Peiwen Kuo; Scott V Bratman; David B Shultz; Rie von Eyben; Cato Chan; Ziwei Wang; Carmen Say; Aparna Gupta; Bill W Loo; Amato J Giaccia; Albert C Koong; Maximilian Diehn; Quynh-Thu Le
Journal:  Clin Cancer Res       Date:  2014-09-04       Impact factor: 12.531

6.  MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype.

Authors:  Ellen Leich; Alberto Zamo; Heike Horn; Eugenia Haralambieva; Bernhard Puppe; Randy D Gascoyne; Wing-Chung Chan; Rita M Braziel; Lisa M Rimsza; Dennis D Weisenburger; Jan Delabie; Elaine S Jaffe; Jude Fitzgibbon; Louis M Staudt; Hans-Konrad Mueller-Hermelink; Mariarita Calaminici; Elias Campo; German Ott; Luis Hernández; Andreas Rosenwald
Journal:  Blood       Date:  2011-09-29       Impact factor: 22.113

Review 7.  When galectins recognize glycans: from biochemistry to physiology and back again.

Authors:  Santiago Di Lella; Victoria Sundblad; Juan P Cerliani; Carlos M Guardia; Dario A Estrin; Gerardo R Vasta; Gabriel A Rabinovich
Journal:  Biochemistry       Date:  2011-08-26       Impact factor: 3.162

8.  High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia.

Authors:  Marco Herling; Kaushali A Patel; Nicole Weit; Nils Lilienthal; Michael Hallek; Michael J Keating; Dan Jones
Journal:  Blood       Date:  2009-09-21       Impact factor: 22.113

Review 9.  Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation.

Authors:  Gabriel A Rabinovich; Marta A Toscano
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

10.  FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation.

Authors:  Goichi Yoshimoto; Toshihiro Miyamoto; Siamak Jabbarzadeh-Tabrizi; Tadafumi Iino; Jennifer L Rocnik; Yoshikane Kikushige; Yasuo Mori; Takahiro Shima; Hiromi Iwasaki; Katsuto Takenaka; Koji Nagafuji; Shin-ichi Mizuno; Hiroaki Niiro; Gary D Gilliland; Koichi Akashi
Journal:  Blood       Date:  2009-10-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.